Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine

Since initial reports in April 2009, the pandemic influenza A (H1N1) virus has spread globally. Influenza vaccines are the primary method for the control of influenza and its complications. We conducted a multicenter clinical trial to evaluate the immunogenicity and safety of H1N1 vaccine (Green Cro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cheong, Hee Jin, Song, Joon Young, Heo, Jung Yeon, Noh, Ji Yun, Choi, Won Suk, Park, Dae Won, Wie, Seong-Heon, Kim, Woo Joo
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2011
Materias:
Vaccine Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3147346/
https://ncbi.nlm.nih.gov/pubmed/21715575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.05111-11
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares